Grp94及miR-3652在乳腺癌中的作用及機(jī)制研究
[Abstract]:Endocrine therapy is commonly used to treat breast cancer with estrogen receptor positive (estrogen receptor positive,ER). Recently, more and more patients have been found to be resistant to endocrine drugs, so the study of molecular targeted drugs is more worthy of attention. A large number of studies have found that endoplasmic reticulum stress (endoplasmic reticulum stress,ERS) is closely related to apoptosis of tumor cells. Drugs directed against ERS have become potential antitumor drugs, but there are relatively few studies on ERS in breast cancer. Glucose-regulated protein 94 (glucose regulated protein94,Grp94) is a marker of ERS. It has been reported that Grp94 is highly expressed in many kinds of cancer cells, such as breast cancer, and its expression level is related to the occurrence, development and poor prognosis of the tumor. Therefore, this experiment selected to study the relationship between Grp94 silencing and ERS mediated apoptosis in ER breast cancer cell MCF-7, and explore the molecular mechanism, which provides a theoretical basis and a new idea for the application of Grp94 in ERS mediated breast cancer therapy. While studying Grp94, we found that there is a micro RNA gene located in the 5 'exon of Grp94 gene, named miR-3652 (micro RNA-3652). We also studied the effects of miR-3652 on the biological characteristics of MCF-7 cells by overexpression of miR-3652,. Part I the mechanism of endoplasmic reticulum stress inducing apoptosis of human breast cancer MCF-7 cells after Grp94 interference objective: to study the relationship between Grp94 interference and ERS mediated apoptosis in human breast cancer MCF-7 cells and to explore the molecular mechanism. Methods: MCF-7 cells were treated with tunicamycin,Tm and ERS model was established in vitro. Under the condition of ERS, si RNA, targeting Grp94 was designed and synthesized to detect the effect of interfering Grp94 on apoptosis by flow cytometry (flow cytometry,FCM), and Western Blotting was used to detect the expression of ERS markers and (unfolded protein response,UPR pathway molecules. Results: in the presence of ERS, the apoptotic rate was increased and the expression of Bip,IRE1,p-JNK increased and the level of Bcl-2 decreased. Conclusion the stress state and apoptosis of the cells increased after the interference of W Grp94, and the effect of promoting apoptosis may be realized by IRE1-JNK-Bcl-2 pathway. The second part: the effect of overexpression of miR-3652 on the biological characteristics of human breast cancer MCF-7 cells objective: to study the effects of overexpression of miR-3652 on the biological characteristics of human breast cancer MCF-7 cells. Methods: the expression of miR-3652 was detected in breast cancer cell line MCF-7,MDA-MB-231 and SK-BR-3. The changes of miR-3652 expression after Grp94 knock down were detected by Real-time PCR at m RNA level, and the relationship between them at transcription level was clarified. MiR-3652 mimics (miR-3652mimics) were designed and synthesized and transfected into MCF-7 cells to verify the overexpression efficiency. The effects of overexpression of miR-3652 on cell cycle and apoptosis were detected by FCM and the changes of cell proliferation after transfection by MTT. Results the expression of miR-3652 in MCF-7 cells was the lowest. The expression of miR-3652 in MCF-7 cells was also decreased after si RNA knocked down, and the difference was statistically significant (P0.01) .miR-3652 mimics could significantly increase the m RNA level of miR-3652 in the cells. Overexpression of miR-3652 had no effect on the cell cycle and apoptosis of MCF-7 cells, but it could significantly promote the proliferation of MCF-7 cells after 48 hours (P0.05). Conclusion the Grp94 expression of the host gene is consistent with that of the host gene, which preliminarily proves that they belong to the same transcription unit, and miR-3652 is regulated by the promoter of the host gene Grp94. Overexpression of miR-3652 had no effect on the cell cycle and apoptosis of MCF-7 cells, but it promoted the proliferation of MCF-7 cells.
【學(xué)位授予單位】:重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R737.9
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 郭秦樂(lè);徐琳;李會(huì)霞;周博;;顆粒蛋白前體(PGRN)通過(guò)活化內(nèi)質(zhì)網(wǎng)應(yīng)激誘導(dǎo)肝細(xì)胞胰島素抵抗的機(jī)制[J];基因組學(xué)與應(yīng)用生物學(xué);2016年12期
2 劉程;劉偉光;陳波;;乳腺癌內(nèi)分泌治療耐藥機(jī)制的研究進(jìn)展[J];現(xiàn)代腫瘤醫(yī)學(xué);2016年16期
3 樊建軍;武家燕;李韻;曾帆;宋方洲;;沉默GRP94基因?qū)θ橄侔㎝CF7細(xì)胞增殖和凋亡的影響[J];中國(guó)免疫學(xué)雜志;2016年06期
4 刁宗禮;郭維康;劉文虎;;內(nèi)質(zhì)網(wǎng)應(yīng)激在糖尿病腎病發(fā)病機(jī)制中的研究進(jìn)展[J];蘭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2016年02期
5 陳娜子;姜潮;李校X;;內(nèi)質(zhì)網(wǎng)應(yīng)激與疾病[J];中國(guó)生物工程雜志;2016年01期
6 魏靜;張建榮;李建民;;內(nèi)質(zhì)網(wǎng)應(yīng)激在糖尿病及糖尿病腎病中的研究進(jìn)展[J];醫(yī)學(xué)綜述;2015年23期
7 伍家燕;高月;曾帆;李海玉;樊建軍;李韻;張寒韜;劉革力;宋方洲;;miR-335對(duì)MDA-MB-231乳腺癌細(xì)胞生物學(xué)特性的影響[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2015年14期
8 黃亨平;吳明松;;內(nèi)質(zhì)網(wǎng)應(yīng)激——腫瘤治療的新靶點(diǎn)[J];現(xiàn)代醫(yī)藥衛(wèi)生;2014年17期
9 韓曉鳳;李美玲;張鵬;夏飛;郭風(fēng)勁;;siIRE1α重組腺病毒對(duì)內(nèi)質(zhì)網(wǎng)應(yīng)激介導(dǎo)凋亡的影響[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2014年11期
10 曾惠愛;劉先領(lǐng);;內(nèi)質(zhì)網(wǎng)應(yīng)激與腫瘤細(xì)胞凋亡[J];腫瘤防治研究;2013年02期
,本文編號(hào):2203091
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2203091.html